Predictive Value of Transabdominal Intestine Sonography in Critically Ill Patients

• Sponsor: Nanjing PLA General Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT03589248
• Collaborator: (none)
• Enrollment: 136
• Actual Duration (Months): 21

Study Details

Study Description

Brief Summary

It is very important to evaluate the degree of gastrointestinal dysfunction in critical ill patients. Thus the investigators conducted transabdominal intestine ultrasonography(US) in critical ill patients to evaluated the degree of gastrointestinal dysfunction under the acute gastrointestinal injury (AGI)

Condition or Disease	Intervention/Treatment	Phase
Gastrointestinal Dysfunction; Critical Illness; Intestine Ultrasonography	Diagnostic Test: GIF score; Diagnostic Test: US score

Study Design

• Study Type: Observational
• Actual Enrollment: 136 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: Predictive Value of Transabdominal Intestine Sonography in Critically Ill Patients：A Prospective, Observational Study
• Actual Study Start Date: Jul 1, 2016
• Actual Primary Completion Date: Jan 1, 2018
• Actual Study Completion Date: Apr 1, 2018

Arms and Interventions

Arm	Intervention/Treatment
GIF score assess the AGI by gastrointestinal failure(GIF) score	Diagnostic Test: GIF score; assessment by GIF score; Diagnostic Test: US score; assessment by ultrasonography score
US score assess the AGI by ultrasonography(US) score	Diagnostic Test: GIF score; assessment by GIF score; Diagnostic Test: US score; assessment by ultrasonography score

Outcome Measures

Primary Outcome Measures

1. predict value of 28-day mortality [one and a half year]

   predict value of 28-day mortality

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 80 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• aged more than 18 years

• Acute Physiology Chronic Health Evaluation II (APACHE II) score >8

Exclusion Criteria:

• uncontrolled mesenteric vascular disease

• uncontrolled chronic organ dysfunction

• advanced cancer

• any terminal stage disease

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Nanjing PLA General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Gao Tao, research assistant, Nanjing PLA General Hospital
• ClinicalTrials.gov Identifier: NCT03589248
• Other Study ID Numbers: 2016NLYZDRC015
• First Posted: Jul 17, 2018
• Last Update Posted: Jul 17, 2018
• Last Verified: Jul 1, 2018

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Critical Illness

Study Results

No Results Posted as of Jul 17, 2018